EXEL Exelixis Inc

$38.55

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-06-30
Expected on May 13, 2025
Report Time: Unknown Release Time
The Whisper Number
$0.36
Consensus Estimate: $0.36
Revenue Estimate: $499.53M

About Exelixis Inc

Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.

Website: https://www.exelixis.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
939767
Address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US
Valuation
Market Cap
$9.97B
P/E Ratio
20.56
PEG Ratio
2.27
Price to Book
4.44
Performance
EPS
$1.76
Dividend Yield
—
Profit Margin
24.00%
ROE
23.10%
Technicals
50D MA
$36.30
200D MA
$31.23
52W High
$40.02
52W Low
$20.14
Fundamentals
Shares Outstanding
276M
Target Price
$37.95
Beta
0.57

EXEL EPS Estimates vs Actual

● Estimated
● Actual

EXEL News & Sentiment

Apr 29, 2025 • Benzinga SOMEWHAT-BULLISH
Is the Market Bullish or Bearish on Exelixis? - Exelixis ( NASDAQ:EXEL )
Exelixis's EXEL short percent of float has risen 25.73% since its last report. The company recently reported that it has 18.23 million shares sold short, which is 9.04% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.97 days to cover ...
Apr 29, 2025 • Zacks Commentary NEUTRAL
Can Amgen Keep the Beat Streak Alive This Earnings Season?
Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Apr 25, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum?
Investors will likely focus on the demand for Cabometyx and pipeline updates when EXEL reports Q1 results.
Apr 24, 2025 • Zacks Commentary NEUTRAL
Earnings Preview: Alkermes ( ALKS ) Q1 Earnings Expected to Decline
Alkermes (ALKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apr 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Exelixis ( EXEL ) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Exelixis (EXEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apr 16, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is First Trust Mid Cap Core AlphaDEX ETF ( FNX ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Sentiment Snapshot

Average Sentiment Score:

0.258
50 articles with scored sentiment

Overall Sentiment:

Bullish

EXEL Reported Earnings

Feb 04, 2025
Dec 31, 2024 (Pre market)
0.06 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.49
  • Whisper: —
  • Surprise %: 11.8%
Oct 29, 2024
Sep 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.40
  • Estimate: $0.35
  • Whisper: —
  • Surprise %: 14.3%
Aug 06, 2024
Jun 30, 2024 (Post market)
0.47 Surprise
  • Reported EPS: $0.77
  • Estimate: $0.30
  • Whisper: —
  • Surprise %: 156.7%
Apr 30, 2024
Mar 31, 2024 (Post market)
-0.04 Surprise
  • Reported EPS: $0.20
  • Estimate: $0.24
  • Whisper: —
  • Surprise %: -16.7%
Feb 06, 2024
Dec 31, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $0.27
  • Estimate: $0.21
  • Whisper: —
  • Surprise %: 28.6%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.0 Surprise
  • Reported EPS: $0.10
  • Estimate: $0.10
  • Whisper: —
  • Surprise %: 0.0%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.09 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.16
  • Whisper: —
  • Surprise %: 56.2%
May 09, 2023
Mar 31, 2023 (Post market)
-0.03 Surprise
  • Reported EPS: $0.12
  • Estimate: $0.15
  • Whisper: —
  • Surprise %: -20.0%
Feb 07, 2023
Dec 31, 2022 (Post market)
0.03 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.12
  • Whisper: —
  • Surprise %: 25.0%

Financials